Note Receivable (Details) - IGH Note [Member] - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | 14 Months Ended | |||
---|---|---|---|---|---|---|---|
Jun. 21, 2021 |
Jul. 12, 2021 |
Aug. 31, 2022 |
Aug. 12, 2022 |
May 31, 2022 |
Aug. 12, 2022 |
Oct. 31, 2018 |
|
Note Receivable (Details) [Line Items] | |||||||
Financing Receivable, after Allowance for Credit Loss, Current | $ 5,000,000 | ||||||
Proceeds from Collection of Notes Receivable | $ 500,000 | $ 500,000 | $ 348,165 | $ 2,000,000 | $ 2,740,820 | $ 3,000,000 | |
Gain (Loss) Related to Litigation Settlement | 348,165 | ||||||
Measurement Input, Default Rate [Member] | |||||||
Note Receivable (Details) [Line Items] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 15.00% | ||||||
Principal [Member] | |||||||
Note Receivable (Details) [Line Items] | |||||||
Proceeds from Collection of Notes Receivable | 333,333 | 2,666,670 | |||||
Accrued Interest [Member] | |||||||
Note Receivable (Details) [Line Items] | |||||||
Proceeds from Collection of Notes Receivable | $ 14,832 | $ 74,150 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|